Centrum gynekologicke rehabilitace s.r.o.
- Address
- lock Available on a paid plan
Gynaecology and Women’s Health Research
The clinical research at Centrum gynekologicke rehabilitace s.r.o. focuses on female urogenital diseases and reproductive and urinary physiological phenomena, with studies centered on common women’s health concerns such as primary dysmenorrhea and pregnancy prevention. These trials are designed to evaluate how well new or existing approaches may relieve menstrual pain and support reliable contraception.
- Evaluating treatment effectiveness for primary dysmenorrhea and menstrual cramping
- Assessing contraceptive efficacy for pregnancy prevention
Overall, the site contributes to practical clinical questions in gynecology, with an emphasis on improving symptom control and reproductive care for women.
Menstrual Pain and Symptom Relief Studies
One area of research examines primary dysmenorrhea, or painful menstruation, in women experiencing lower abdominal cramping around their menstrual cycle. The purpose of this work is to test whether a potential therapy can reduce pain and improve comfort compared with a control approach.
- Studying primary dysmenorrhea and menstrual cramping
- Testing a new option for easing menstrual pain
This line of research is relevant for patients seeking better management of recurring period-related pain and for clinicians looking for more effective non-surgical options.
Contraception and Pregnancy Prevention Research
Another trial area at this research site focuses on prevention of pregnancy, with attention to the effectiveness, safety, and tolerability of a contraceptive method. The goal is to determine how well the approach supports dependable birth control in real-world use.
- Investigating contraceptive efficacy
- Studying pregnancy prevention options for women
By concentrating on reproductive health, the site’s work helps inform choices about family planning and everyday contraceptive care.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 634 other sites in Czechia
Therapeutic Area Benchmark — Czechia
Select a therapeutic area to compare against other sites in Czechia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Czechia
Market Share
Country: Czechia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centrum gynekologicke rehabilitace s.r.o.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A multicentre, single arm trial on contraceptive efficacy, safety and tolerability of LVDS (Levonorgestrel Vaginal Delivery System) during 13 cycles. | Chemo Research S.L. | Phase III | Not Recruiting | Jul 2023 | Aug 2025 |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Levonorgestrel | 1 | Unknown | 2023-07-12 | 2023-07-12 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.